Yubo Q. Yan

Changjiang Road 600
Harbin, 150030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Retraction notice to "MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway" [Cellular Signalling 73 (2020) 109675].

Retraction notice to "MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway" [Cellular Signalling 73 (2020) 109675].

Journal: Cellular signalling

Published: September 04, 2026

SLC16A7 and WDR38 form a mitochondrial-centric axis driving lung cancer through metabolic reprogramming and REDOX adaptation.

SLC16A7 and WDR38 form a mitochondrial-centric axis driving lung cancer through metabolic reprogramming and REDOX adaptation.

Journal: Journal of translational internal medicine

Published: April 28, 2026

Efficacy and mechanisms of cisplatin and sulforaphane nanoparticles in alleviating cisplatin resistance in non-small cell lung cancer.

Efficacy and mechanisms of cisplatin and sulforaphane nanoparticles in alleviating cisplatin resistance in non-small cell lung cancer.

Journal: Translational lung cancer research

Published: September 29, 2025

The role of exosomal PD-L1 in NSCLC immunotherapy.

The role of exosomal PD-L1 in NSCLC immunotherapy.

Journal: Immunotherapy

Published: July 30, 2025

YY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation.

YY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation.

Journal: Cell death & disease

Published: July 18, 2025

Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications.

Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications.

Journal: Molecular cancer

Published: July 03, 2025

Peptide YY fragment PYY1-36 disrupts mitochondrial biogenesis via RBM43-dependent PGC-1α translation inhibition.

Peptide YY fragment PYY1-36 disrupts mitochondrial biogenesis via RBM43-dependent PGC-1α translation inhibition.

Journal: Investigational new drugs

Published: March 10, 2025

Research Progress on Marine Natural Products for Diabetes: From Mechanistic Insights to Compound Exploration.

Research Progress on Marine Natural Products for Diabetes: From Mechanistic Insights to Compound Exploration.

Journal: Current topics in medicinal chemistry

Published: March 03, 2025

Spatial transcriptomics reveals macrophage domestication by epithelial cells promotes immunotherapy resistance in small cell lung cancer.

Spatial transcriptomics reveals macrophage domestication by epithelial cells promotes immunotherapy resistance in small cell lung cancer.

Journal: NPJ precision oncology

Published: February 21, 2025

The relationship between blood biomarkers and prognosis of pathologic stage IA pure-solid non-small cell lung cancer patients.

The relationship between blood biomarkers and prognosis of pathologic stage IA pure-solid non-small cell lung cancer patients.

Journal: Journal of thoracic disease

Published: December 02, 2024

RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.

RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.

Journal: Oncology reports

Published: October 23, 2024

NADH:ubiquinone oxidoreductase core subunit S8 expression and functional significance in non-small cell lung cancer.

NADH:ubiquinone oxidoreductase core subunit S8 expression and functional significance in non-small cell lung cancer.

Journal: Cell death & disease

Published: September 29, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026